Jason S. Lewis
Jason S. Lewis
Verified email at mskcc.org
Cited by
Cited by
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy
KSC Chao, WR Bosch, S Mutic, JS Lewis, F Dehdashti, MA Mintun, ...
International Journal of Radiation Oncology* Biology* Physics 49 (4), 1171-1182, 2001
Copper radionuclides and radiopharmaceuticals in nuclear medicine
PJ Blower, JS Lewis, J Zweit
Nuclear medicine and biology 23 (8), 957-980, 1996
Imaging biomarker roadmap for cancer studies
JPB O'Connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response—a preliminary report
F Dehdashti, PW Grigsby, MA Mintun, JS Lewis, BA Siegel, MJ Welch
International Journal of Radiation Oncology* Biology* Physics 55 (5), 1233-1238, 2003
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
F Dehdashti, MA Mintun, JS Lewis, J Bradley, R Govindan, R Laforest, ...
European journal of nuclear medicine and molecular imaging 30 (6), 844-850, 2003
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model
JS Lewis, DW McCarthy, TJ McCarthy, Y Fujibayashi, MJ Welch
Journal of Nuclear Medicine 40 (1), 177-183, 1999
89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo
JP Holland, V Divilov, NH Bander, PM Smith-Jones, SM Larson, JS Lewis
Journal of Nuclear Medicine 51 (8), 1293-1300, 2010
Metal complexes as diagnostic tools
DE Reichert, JS Lewis, CJ Anderson
Coordination Chemistry Reviews 184 (1), 3-66, 1999
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors
CJ Anderson, F Dehdashti, PD Cutler, SW Schwarz, R Laforest, LA Bass, ...
Journal of Nuclear Medicine 42 (2), 213-221, 2001
Imaging oxygenation of human tumours
AR Padhani, KA Krohn, JS Lewis, M Alber
European radiology 17 (4), 861-872, 2007
Standardized methods for the production of high specific-activity zirconium-89
JP Holland, Y Sheh, JS Lewis
Nuclear medicine and biology 36 (7), 729-739, 2009
Copper bis (thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships
JL Dearling, JS Lewis, GE Mullen, MJ Welch, PJ Blower
JBIC Journal of Biological Inorganic Chemistry 7 (3), 249-259, 2002
PET imaging with 89Zr: from radiochemistry to the clinic
MA Deri, BM Zeglis, LC Francesconi, JS Lewis
Nuclear medicine and biology 40 (1), 3-14, 2013
Cerenkov luminescence imaging of medical isotopes
A Ruggiero, JP Holland, JS Lewis, J Grimm
Journal of Nuclear Medicine 51 (7), 1123-1130, 2010
Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis
RS Prakash, EM Snook, JM Lewis, RW Motl, AF Kramer
Multiple Sclerosis Journal 14 (9), 1250-1261, 2008
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
K Moulick, JH Ahn, H Zong, A Rodina, L Cerchietti, EMG DaGama, ...
Nature chemical biology 7 (11), 818, 2011
Small animal imaging: current technology and perspectives for oncological imaging
JS Lewis, S Achilefu, JR Garbow, R Laforest, MJ Welch
European journal of cancer 38 (16), 2173-2188, 2002
Copper-64-diacetyl-bis (N4-methylthiosemicarbazone): An agent for radiotherapy
JS Lewis, R Laforest, TL Buettner, SK Song, Y Fujibayashi, JM Connett, ...
Proceedings of the National Academy of Sciences 98 (3), 1206-1211, 2001
Tumor uptake of copper-diacetyl-bis (N4-methylthiosemicarbazone): effect of changes in tissue oxygenation
JS Lewis, TL Sharp, R Laforest, Y Fujibayashi, MJ Welch
Journal of Nuclear Medicine 42 (4), 655-661, 2001
A pretargeted PET imaging strategy based on bioorthogonal Diels–Alder click chemistry
BM Zeglis, KK Sevak, T Reiner, P Mohindra, SD Carlin, P Zanzonico, ...
Journal of nuclear medicine 54 (8), 1389-1396, 2013
The system can't perform the operation now. Try again later.
Articles 1–20